Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

688505

Company Profile

  • Business description

    Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

  • Contact

    308 Cailun Road
    Zhangjiang Hi-Tech Park
    Pudong
    Shanghai201210
    CHN

    T: +86 2158953355

    http://www.fd-zj.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    899

Stocks News & Analysis

stocks

ChatGPT enters the retail space and one company surges

Investors cheer the ability to purchase directly from ChatGPT.
stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,135.9019.50-0.21%
CAC 407,857.3823.49-0.30%
DAX 4023,774.5729.510.12%
Dow JONES (US)46,316.0768.780.15%
FTSE 1009,316.8016.960.18%
HKSE26,855.56232.680.87%
NASDAQ22,591.15107.090.48%
Nikkei 22544,932.63111.12-0.25%
NZX 50 Index13,292.36159.801.22%
S&P 5006,661.2117.510.26%
S&P/ASX 2008,848.8020.50-0.23%
SSE Composite Index3,882.7820.250.52%

Market Movers